A comparison study of multiple measures of adherence to HIV protease inhibitors.
about
HIV Treatment Adherence, Drug Resistance, Virologic Failure: Evolving ConceptsPatient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDSMedication Adherence Measures: An OverviewRelationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failureAdherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysisHepatitis C virus infection in san francisco’s HIV-infected urban poorAdherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in BotswanaImproved completion rates and characterization of drug reactions with an intensive Chagas disease treatment program in rural BoliviaLamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in ChinaClinical Outcomes Associated with Medication Regimen Complexity in Older People: A Systematic Review.Getting to 90-90-90 in paediatric HIV: What is needed?Visual analogue scale (VAS) measurement of antiretroviral adherence in people living with HIV (PLWH): a meta-analysis.Adherence and its measurement in phase 2/3 microbicide trials.Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence".Super Learner Analysis of Electronic Adherence Data Improves Viral Prediction and May Provide Strategies for Selective HIV RNA Monitoring.Estimating treatment effect in the presence of non-compliance measured with error: precision and robustness of data analysis methods.Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models.Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic reviewAssociations between the legal context of HIV, perceived social capital, and HIV antiretroviral adherence in North America.Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients.Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence.Performance of two questionnaires to measure treatment adherence in patients with Type-2 diabetesProspective State and Trait Predictors of Daily Medication Adherence Behavior in HIV.Supporting children to adhere to anti-retroviral therapy in urban Malawi: multi method insights.Measuring adherence to antiretroviral treatment in resource-poor settings: the clinical validity of key indicators.Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators.A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA.Monitoring microbicide gel use with real-time notification of the container's opening events: results of the CAPRISA Wisebag studyPatterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherenceAnalyzing adherence to prenatal supplement: does pill count measure up?Access to antiretroviral therapy for adults and children with HIV infection in developing countries: Horizons studies, 2002-2008An examination of the psychometric properties of the Antiretroviral General Adherence Scale (AGAS) in two samples of HIV-infected individuals.Determinants of compliance with malaria chemoprophylaxis among French soldiers during missions in inter-tropical AfricaDeveloping useful highly active antiretroviral therapy adherence measures for India: the Prerana study.Randomized control trial of peer-delivered, modified directly observed therapy for HAART in MozambiquePatient-level moderators of the efficacy of peer support and pager reminder interventions to promote antiretroviral adherence.Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort studyRationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study.Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study
P2860
Q22241321-6CD18CE1-64EC-457E-9858-F87F9E68BE00Q24245348-693F7B03-A396-4A8B-A996-FDFCAB1C4636Q26779213-E0ED0D99-91C9-45C2-BB20-98D095A0642BQ27003431-87526DB2-6AF6-4816-BF47-AD00ED88D061Q27024379-49836F26-15A3-4E81-A8F5-39D90E5425B1Q27473306-441CC2F9-A52E-4C4F-8518-A92492ED6C1FQ28221847-186764B8-EA0A-423E-B27D-C55BA820692FQ28533625-85BADB78-6EF0-45CE-A680-EE04912A40DDQ28551633-95835061-F42C-4BAC-BD91-338D08CBBC47Q30240010-06A3C43C-F344-46DB-AAC1-2DE8AFEE9CF8Q30385352-E02801B5-F50A-4200-9CFB-039334FEB4F8Q30391305-36805D21-C7B1-47D6-895E-F861BD7AD122Q30496720-8D13A1DC-4B2B-427B-AD55-6A243B9BF492Q30847604-62A5BCF9-B902-4028-B1BB-A8A2E068A2E8Q30936928-D01AF509-8605-4E66-A762-FB7FC211778EQ30944694-B256C112-83BA-48B5-B780-A470F8466D13Q30975802-3CAF4482-8EF0-445B-90CF-1C9DB007025BQ30985350-A0C4D804-2FDB-4D85-B309-A60699E48114Q31010456-690E70DE-09FB-4AD3-8895-8AD1E10A4F56Q31125998-8E4535C3-DFFD-45D4-84C0-3DAAAF369DE1Q33320339-A9A9581A-99AF-4CD3-9CF1-4C5545E5EBF4Q33393729-6B940B8D-C77B-4893-B675-4DF3DF0E6FF3Q33403086-12E73285-6FB1-447E-B93F-2E37B5181D94Q33455270-1B896230-F4FC-4AA3-9BF7-2E8B5813F084Q33481996-9099E499-5AFF-4DF9-91FA-D2D3F7E1DDC2Q33532758-1A477E45-29A6-4B26-85C4-B9F5009711DAQ33532759-B93F71CE-5DE1-4DAC-AD54-324FB243D063Q33553219-636F0AE9-B0EA-4FC7-9F88-20525E235089Q33601594-22AF6EA1-5CBF-436B-9048-FF462C168520Q33637963-AA28A0F0-8175-4A8F-922C-908DAFA7B32AQ33651865-C33E116A-47AC-488F-86AF-B53165A33E38Q33652805-286F38F6-4D24-439F-8BEB-3B3C3770D552Q33679085-29EDF7A7-87A1-486F-A712-B79A59A86350Q33690072-2D0978DC-141E-4B64-B98C-0288000C0FE3Q33699710-9A5E61FE-881A-4E2A-B36D-FDA866C5BCF5Q33707611-18CA5E41-8B2F-4887-A392-DC015D0CCB69Q33707680-8A191FDE-F9CF-40B0-98D9-A530CC0418A1Q33737751-72B6802B-5E04-4AF6-B381-37CB8023B550Q33741119-3052F041-C40B-4D9E-99D4-1462C8AD87C8Q33753312-01D070BC-9F83-43D6-AF51-98D682A982A6
P2860
A comparison study of multiple measures of adherence to HIV protease inhibitors.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A comparison study of multiple measures of adherence to HIV protease inhibitors.
@en
A comparison study of multiple measures of adherence to HIV protease inhibitors.
@nl
type
label
A comparison study of multiple measures of adherence to HIV protease inhibitors.
@en
A comparison study of multiple measures of adherence to HIV protease inhibitors.
@nl
prefLabel
A comparison study of multiple measures of adherence to HIV protease inhibitors.
@en
A comparison study of multiple measures of adherence to HIV protease inhibitors.
@nl
P2093
P1476
A comparison study of multiple measures of adherence to HIV protease inhibitors.
@en
P2093
Christian J
Maldonado T
Sanandaji S
P304
P356
10.7326/0003-4819-134-10-200105150-00011
P407
P577
2001-05-01T00:00:00Z